Lipocine (LPCN) investor relations material

Executive summary

• Annual meeting scheduled for June 3, 2026, at the company’s Salt Lake City office.

• Shareholders are invited to vote on key proposals, including director elections and compensation matters.

Voting matters and shareholder proposals

• Election of four directors: Mahesh V. Patel, John W. Higuchi, Jill M. Jene, and Richard Dana Ono.

• Ratification of Tanner LLC as the independent registered public accounting firm.

• Advisory vote on executive compensation (say-on-pay) for named executive officers.

• Amendment to the 2014 Stock and Incentive Plan to increase individual award limits and total authorized shares.

• Approval to adjourn the meeting if additional vote solicitation is needed.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and proposals.